期刊
ADVANCED HEALTHCARE MATERIALS
卷 10, 期 1, 页码 -出版社
WILEY
DOI: 10.1002/adhm.202001207
关键词
nanocarriers; precise phototherapy; switches; targeted drug delivery; tumors
资金
- National Natural Science Foundation of China [51825302, 31900991, 21734002, 51673032]
- Key Scientific Research Projects, Education Department of Henan Province [20A350009]
The key to precise tumor phototherapy is to ensure that ROS or heat is specifically generated at the tumor site, while the phototoxicity of conventional PAs is one of the main challenges for their potential clinical application. Through targeted delivery of PAs and activatable phototherapy strategies based on nanocarriers, precise treatment of tumors can be achieved.
Phototherapy, including photodynamic therapy and photothermal therapy, mainly relies on phototherapeutic agents (PAs) to produce heat or toxic reactive oxygen species (ROS) to kill tumors. It has attracted wide attention due to its merits of noninvasive properties and negligible drug resistance. However, the phototoxicity of conventional PAs is one of the main challenges for its potential clinical application. This is mainly caused by the uncontrolled distribution of PA in vivo, as well as the inevitable damage to healthy cells along the light path. Ensuring the generation of ROS or heat specific at tumor site is the key for precise tumor phototherapy. In this review, the progress of targeted delivery of PA and activatable phototherapy strategies based on nanocarriers for precise tumor therapy is summarized. The research progress of passive targeting, active targeting, and activatable targeting strategies in the delivery of PA is also described. Then, the switchable nanosystems for tumor precise phototherapy in response to tumor microenvironment, including pH, glutathione (GSH), protein, and nucleic acid, are highlighted. Finally, the challenges and opportunities of nanocarrier-based precise phototherapy are discussed for clinical application in the future.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据